Big pharma megamerger

A $160 billion deal to merge Pfizer and Dublin-based Allergan will create a drug powerhouse with combined revenue of $62.7bn. Pfizer will move its tax base to Ireland to slash its U.S. tax bill by $21bn

Johnson
& Johnson

$74.33bn

Novartis

$57.99bn

Roche

$49.86bn

Pfizer

$49.61bn

$13.10bn

Sanofi

$43.07bn

Allergan

Merck & Co

$42.24bn

GlaxoSmithKline

$37.96bn

AstraZeneca

$26.10bn

Top 10 pharmaceutical
companies by 2014 revenue

Bayer
HealthCare

$25.47bn

Gilead Sciences

$24.47bn

0

10

20

30

40

50

60

70

80

Top-selling
medications

Lyrica — $5.16 billion
(epilepsy, neuropathy)
Prevnar — $4.46 billion
(prevention of pneumococcal pneumonia)
Viagra — $1.68 billion (erectile dysfunction)

Botox — $2 billion*
(anti-wrinkle treatment)
Restasis — $940 million*
(dry-eye treatment)

Sources: Fierce Pharma, Contract Pharma, Statista

*2013 figures

© GRAPHIC NEWS